How many institutions held NVNO - enVVeno Medical Corporation - Common Stock, $0.00001 par value in Q1 2024?

31 institutional investors reported NVNO - enVVeno Medical Corporation - Common Stock, $0.00001 par value for Q1 2024. Use the holders table for investor-level position and value details.

enVVeno Medical Corporation - Common Stock, $0.00001 par value (NVNO)

Q: What does CUSIP 29415J106 represent in this 13F holders report?

CUSIP 29415J106 is the security identifier for NVNO - enVVeno Medical Corporation - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 29415J106

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock, $0.00001 par value
Total 13F shares: 3,643,857
Total 13F value: $19,822,808
Share change: -604,774
Put/Call ratio: 6.5%
SEC-reported price per share: $5.44
Number of holders: 31
Value change: -$2,947,912
Number of buys: 21
Number of sells: 14
Shares outstanding: 685,936

Security key

29415J106

Report period

Q1 2024

Institutions

Top holders

NVNO full security history Ownership snapshot Full 13F holder table enVVeno Medical Corp SEC filings enVVeno Medical Corp company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NVNO - enVVeno Medical Corporation - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Nantahala Capital Managem...

Disclosed value leader

Nantahala Capital Managem...

Comparable rows

15/15

Latest evidence

31 Dec 2023

13F Lead comparable stake: 103% Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC leads the comparable SEC ownership view at 103%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.

Comparable ownership Top 5

Nantahala Capital Management, LLC 103%

PERCEPTIVE ADVISORS LLC 91%

KINGDON CAPITAL MANAGEMENT, L.L.C. 90%

ARMISTICE CAPITAL, LLC 64%

Altium Capital Management LLC 50%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Nantahala Capital Management, LLC	13F Company 13F	103%	$3,630,480 706,319 shares	—	31 Dec 2023
PERCEPTIVE ADVISORS LLC	13F Company 13F	91%	$3,203,839 623,315 shares	—	31 Dec 2023
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F Company 13F	90%	$3,182,585 619,180 shares	—	31 Dec 2023
ARMISTICE CAPITAL, LLC	13F Company 13F	64%	$2,241,040 436,000 shares	—	31 Dec 2023
Altium Capital Management LLC	13F Company 13F	50%	$1,770,581 344,471 shares	—	31 Dec 2023
VANGUARD GROUP INC	13F Company 13F	49%	$1,729,121 336,405 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,643,857

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %